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Post-operative arrhythmiasAims: The aims of this study are to investigate the incidence and determinants of post-operative atrial arrhyth-
mias, conduction disorders and mortality in hypertrophic obstructive cardiomyopathy (HOCM) patients under-
going transaortic myectomy.
Methods and results: This retrospective single-center study was conducted in 249 patients (median age 54 years
[40–64], 42% female) undergoing transaorticmyectomy. Post-operative atrial fibrillation (AF)was reported in 84
patients (33.7%), including 56 patients (22.5%) with de novo AF. Older age (HR = 1.027 (1.003–1.052), p =
0.029) and hypercholesterolemia (HR = 2.296 (1.091–4.832) p = 0.029) were independent predictors for de
novo post-operative AF. Late post-operative AF and atrial flutter (AFL) occurred in 18.9% and 6.8% of the patients,
respectively. De novo early post-operative AF increased the risk of late post-operative AF (HR = 3.138
(1.450–6.789), p = 0.004). Patients with a right bundle branch block had a higher risk of early-postoperative
pacemaker implantation (p = 0.003, HR = 9.771 (2.195–43.505)). Higher age at time of surgery (HR = 1.053
(1.026–1.081), p < 0.001) was a predictor for late mortality (n = 47, 18.9%).
Conclusion: Early and late post-operative AF, AFL and other SVTs are common sequelae after myectomy and are
associated with older age at surgery, history of AF and early post-operative AF. Early post-operative arrhythmias
are not transient and periodic rhythmmonitoring is therefore essential to initiate therapy as soon as possible.
© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hypertrophic obstructive cardiomyopathy (HOCM) is a structural
heart disease that affects 0.2% of the general population and is the lead-
ing cause of sudden cardiac death in young adults [1,2]. HOCM is pre-
dominantly an obstructive heart disease characterized by dynamic
subaortic gradients which are mainly produced by interventricular sep-
tal hypertrophy and systolic anterior motion (SAM) of the anterior mi-
tral valve leaflet. The SAM inevitably also results in mitral valve
regurgitation and its severity varies with degree of left ventricular out-
flow tract (LVOT) obstruction [1]. Diastolic dysfunction, mitral valve re-
gurgitation and LVOT obstruction result in increased left atrial pressure
and eventually atrial dilatation. These factors predispose this population
to atrial tachyarrhythmias of which atrial fibrillation (AF) is most com-
mon, with an incidence surpassing 20% [3].rophysiology, Department of
plein 40, 3015 GD Rotterdam,
e Groot).
.V. This is an open access article und
. Lodder, A.A.Y. Ragab, et al.,
f Cardiology, https://doi.org/According to the 2014 European Society of Cardiology (ESC) guide-
lines on HOCMmanagement, surgical myectomy is the preferred treat-
ment in patients with an indication for septal reduction, as opposed to
other contemporary invasive strategies, such as alcohol ablation [1]. Be-
cause of the anatomical location of the atrioventricular node and bundle
branches, atrioventricular and interventricular conduction disorders are
common direct sequelae of surgical myectomy [4–6]. Septal myectomy,
results in amelioration of symptoms, improvement in New York Heart
Association (NYHA) class and reduction of mortality [5,7–9]. Neverthe-
less, patients who underwent septal myectomy remain at high risk for
developing conduction disorders and arrhythmias, especially a left bun-
dle branch block and atrial fibrillation (AF) which is poorly tolerated in
HOCM patients. Loss of atrial kick in combination with high ventricular
rates reduces cardiac output, especially in the presence of severe dia-
stolic dysfunction.
AF in HOCM patients is associated with impaired quality of life [3],
heart failure and all-cause mortality [10,11]. As stated in the guidelines,
incidences and characteristics of early and late post-operative AF after
myectomy are poorly investigated [1]. The reported incidence of early
and late post-operative AF ranges from 8 to 29% and 21–30%,er the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tients, differences in surgical management of AF and incomplete docu-
mentation of early and late post-operative atrial tachyarrhythmias
impair reliable comparison of study outcomes. Moreover, none of
these studies report on progression of paroxysmal AF tomore persistent
types of AF.
Therefore, we aimed to investigate the incidence and determinants
of post-operative atrial arrhythmias, conduction disorders and mortal-
ity in HOCM patients undergoing transaortic myectomy.
2. Methods
This retrospective study (MEC-2018-1385) was approved by the
local ethics committee of the ErasmusUniversityMedical Center Rotter-
dam. Informed consent was waived as this study is retrospective in
nature.
2.1. Study population
Adult HOCM patients undergoing transaortic septal myectomy from
February 1972 until July 2017 at our center were included. Patients
were recruited from our surgical database. Patient data was collected
from digital patient records by analyzing electronic records, Holter re-
ports, electrocardiograms (ECGs) and echocardiography reports.
2.2. Arrhythmias
All available post-operative rhythm registrations and correspon-
dence were evaluated for the occurrence of (1) sinus node dysfunction
(SND), (2) first-, second- and third-degree atrioventricular block (AVB),
(3) left- and right bundle branch block or intraventricular conduction
delay, (4) AF, (5) AFL and (6) regular SVT, not specified. Arrhythmias
were defined according to the guidelines [16,17]. Arrhythmias occur-
ring within 30 days after myectomy were defined as early post-
operative arrhythmias.
2.3. Pre-, intra- and post-operative data
Baseline characteristics, presence cardiovascular risk factors, echo-
cardiographic variables, indications for pacemaker implantations were
all obtained from digital patient records. PR- and QRS-duration were
calculated frompre-operative ECGs. Intra-operative data regarding con-
comitant cardiac surgerywas also collected. Post-operative data regard-
ing early- and late post-operative arrhythmias, echocardiographic
variables, ischemic neurological events, mortality rates and cause of
death were also retrieved from electronic patient files. Early mortality
after myectomy was defined as mortality within 30 days after surgery
or longer when the patient was still in hospital.
2.4. Pacemaker implantation
Early post-operative pacemaker implantation was defined as proce-
dures scheduled within 30 days after myectomy. Indications for pace-
maker therapy were reported for every patient separately.
2.5. Statistical analyses
Normality was assessed using the Kolmogorov-Smirnov test. Base-
line characteristics are denoted as mean ± standard deviation for nor-
mally distributed continuous variables and median with interquartile
range (IQR) for skewed data. Differences in means and medians were
calculated using the Student t-test or Mann-Whitney U test or
Kruskal-Wallis test, respectively. Categorical data is presented as num-
bers and percentages and compared with the chi-squared test or,
when appropriate, the Fisher exact test. Kaplan-Meier survival curves
were compared using log-rank statistics. Possible predictors of post-2
operative arrhythmias, pacemaker implantation or mortality were de-
termined usingmultivariable Cox regression analysis, entering variables
with a p-value <0.2 derived from univariable Cox regression analyses.
Hazard ratios (HRs) are reported with 95% confidence intervals (CIs).
A p-value of <0.05 was considered statistically significant. Statistical
analyses were performed using IBM SPSS Statistics version 25 (IBM
Corp., Armonk, New York).
3. Results
3.1. Study population
A total of 249 adult HOCM patients who underwent transaortic sep-
tal myectomy were included. Clinical characteristics of the study popu-
lation are summarized in Table 1. Median age at surgery was 54 years
(range [17–80]). Median follow-up duration of the entire cohort was
3 years [IQR: 0.6–8.9, maximal follow-up: 45.6 years]. As illustrated in
Table 1, a genetic mutation was found in 50.8% of the patients who
underwent genetic testing.
3.2. Patient characteristics
The majority of the patients (n = 148, 59.4%) were either in NYHA
class III or IV prior surgery. At baseline, a pacemaker devicewas present
in 5 (all DDD-pacemakers) patients and a total of 49 patients (19.7%)
had a history of AF (paroxysmal AF:36, (longstanding) persistent AF:9,
unspecified type of AF:4).
3.3. Concomitant procedures and re-operations
During primary repair, the majority of the patients also underwent
concomitant mitral valve surgery (mitral valve repair:178 (71.5%) or
mitral valve replacement:14 (5.6%)). A minority of the patients
underwent concomitant aortic valve- or coronary artery bypass surgery
(CABG) (aortic valve repair/replacement:13, CABG:10 and Bentall:2).
Only one patient, with a history of paroxysmal AF, underwent concom-
itant surgical pulmonary vein isolation. Early post-operative interven-
tions for bleeding or tamponade were required in 38 patients (15.2%).
During follow-up, 23 patients (9.2%) underwent cardiac re-operation
for different indications which are further specified in Supplemental
Table 1.
3.4. Early post-operative echocardiographic findings
Echocardiographic examination in the early post-operative period
showed a decrease in interventricular septum thickness from 20 mm
[17–23] to 15 mm [13–17]. LVOT gradient decreased from 88 mmHg
(70–100) to 12 mmHg (9–20). Early post-operative moderate (n = 9)
and severe LVOT (n = 1) obstruction were rarely observed.
3.5. Early post-operative arrhythmias
Early post-operative arrhythmias were reported in 90 patients
(36.1%). Post-operative AF was most common and occurred in 84 pa-
tients (33.7%), including 56patients (22.5%)with de novo AF. Atrialflut-
ter was observed in 4 patients and 4 patients experienced SVT episodes.
Uni- and multivariate analyses of determinants for early post-
operative AF are shown in Table 2 (de novo post-operative AF) and Sup-
plemental Table 2. Multivariate analysis showed that higher age at time
of surgery (HR = 1.024 (1.002–1.047), p = 0.035) and a history of AF
(HR= 3.273 (1.651–6.488), p=0.001) were both independently asso-
ciated with the occurrence of early post-operative AF. Subanalyses of
patients who developed de novo post-operative AF revealed that age
(HR = 1.027 (1.003–1.052), p = 0.029) and hypercholesterolemia
(HR = 2.296 (1.091–4.832), p = 0.029) appeared to be independent




Number of patients 249 (100)
Age (years) 53.6 [39.9–64.2]
Male gender 145 (58.2)
Body mass index (kg/m2) 26.5 [24.2–29.6]





Genetic testing 128 (51.4)








Negative genetic test 63 (49.2)
AF in history 49 (19.7)
Paroxysmal AF 36 (14.5)
Longstanding (persistent) AF 9 (3.6)
Unspecified type AF 4 (1.6)
Pre-operative ICD 18 (7.2)
Pre-operative PM 5 (20)
Cardiovascular risk factors




Median PR interval (n = 135) 180 ms [160–200]
Median QRS duration (n = 144) 100 ms [90–110]
1st degree AVB 37 (14.9)
Left bundle branch block 12 (4.8)
Right bundle branch block 10 (4)
Interventricular conduction delay 22 (8.8)
Echocardiographic reports available 234 (94)
Left ventricular function
Normal 146 (58.6)
Mild dysfunction 9 (3.6)
Moderate dysfunction 2 (0.8)
Severe dysfunction 2 (0.8)
Not reported 75 (30.1)
Right ventricular function
Normal 14 (5.6)
Not reported 220 (88.4)






Grade unspecified 120 (48.2)
IVS thickness (mm) 20 (17–23)





Left atrial dilatation 51 (20.5)
Right atrial dilatation 4 (1.6)
Pre-operative use of AAD 212 (85.1)
Class I 9 (3.6)
Class II 151 (60.6)
Class III 33 (13.3)
Class IV 94 (37.8)
AAD = Antiarrhythmic drugs, AF = Atrial fibrillation, AVB = Atrioventricular block,
ICD= Internal cardiac defibrillator, IVS=Interventricular septum, LVOT=Left ventricular
outflow tract, MVR = Mitral valve repair or replacement, NYHA = New York Heart
Association.
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3.6. Late post-operative arrhythmias
Late post-operative AF occurred in 47 patients (18.9%) and regular
SVTs were documented in 47 patients (18.9%, no sex differences, p =
0.244). Late post-operative Holtermonitoringwas performed in 110pa-
tients (44.2%) of whom46were diagnosedwith an episode of AF or reg-
ular SVT.
As demonstrated in Table 3, patients who had developed de novo
early post-operative AF after myectomy, were more than 3 times at
higher risk for developing AF during follow-up (HR = 3.138
(1.450–6.789), p=0.004). At the endof the follow-up period, 4 patients
(1.6%) had persistent AF and 19 patients (7.6%) had (longstanding) per-
sistent AF. Late post-operative AFL occurred in aminority of the patients
(n = 17, 6.8%, no sex differences; p = 0.11). Patients with AF prior to
myectomy also had an increased risk for developing late AFL
(p < 0.001); co-existence of AF and AFL was present in 14 patients
(29.7% of all AF patients).3.7. Progression of atrial fibrillation
Fig. 1 shows the duration of progression from paroxysmal AF to per-
sistent or long-standing persistent AF. Progression from paroxysmal AF
to persistent (blue bars) or longstanding persistent AF (red bars) was
observed in 4 and 16 patients, respectively. Out of these 20 patients, 5
patients had a history of AF at time of surgery (4 paroxysmal- and 1 per-
sistent AF) and progressed to (longstanding) persistent AF after a me-
dian follow-up duration of 4.9 years [2.2–9.3]. The remaining 15
patients were diagnosed with paroxysmal AF after a median follow-up
of 9.4 years [0.3–18.9] after surgery. The majority of these patients
(n = 13) progressed from paroxysmal AF to longstanding persistent
AF (median duration 2.5 years [1.3–11.0]) and 3 patients from paroxys-
mal AF to persistent AF (median duration 4 years [1.1–9.1]).3.8. Early and late post-operative pacemaker implantation
During follow-up, post-operative pacemaker implantation was indi-
cated in 23 patients (9.2%). As demonstrated in Supplemental Table 3,
main indication for pacemaker implantation was 2nd or 3rd degree
atrioventricular conduction disorders (73.9%). The majority of the pa-
tients received a pacemaker in the early post-operative period (65.2%).
In contrast to patients with a pre-operative 1st degree AVB (p =
0.402, HR = 1.774 (0.464–6.776)) or LBBB (p = 0.626, HR = 1.697
(0.202–14.250)), patients with RBBB had a higher risk of early-
postoperative pacemaker implantation due to development of 2nd or
3rd degree atrioventricular conduction disorders (p = 0.003, HR =
9.771 (2.195–43.505)). For patients receiving a pacemaker in the late
post-operative period, median time to implantation was 13.4 years
[0.5–18.1].3.9. Mortality
A total of 47 patients (18.9%) died during follow-up with a median
survival time of 9.2 years [3.5–19.4] after myectomy (Supplemental
Fig. 1) and 3 underwent heart transplantation. Only 1 patient died in
the early post-operative period after a re-operation (0.4%). This patient
developedmassive paravalvular aortic valve regurgitation and died due
to acute heart failure. In the remaining patients, main causes of late
mortality could be retrieved in 32 patients (68%) and consisted of
heart failure (n=11), sepsis (n=6), sudden cardiac death (n=5),ma-
lignancy (n = 4), neurovascular causes (n = 2), rejection after heart
transplant (n = 1) and by accident (n = 2). Patients who were older
at time of surgery appeared to have a higher mortality risk
(p < 0.001). Development of post-operative AF did not affect survival
(Supplemental Table 4).
Table 2
Factors associated with early de novo post-operative atrial fibrillation.
Determinant Univariate analysis HR (95% CI) p-value Multivariate analysis HR (95% CI) p-value
Age at repair 1.036 (1.013–1.059) 0.002 1.027 (1.003–1.052) 0.029
Baseline NYHA III/IV 1.333 (0.607–2.928) 0.473
Female sex 1.278 (0.702–2.325) 0.422
Diabetes 0.550 (0.156–1.941) 0.353
Hypertension 1.763 (0.938–3.313) 0.078 1.187 (0.603–2.334) 0.620
Hypercholesterolemia 3.183 (1.580–6.415) 0.001 2.296 (1.091–4.832) 0.029
Use of AAD 1.061 (0.455–2.473) 0.891
Concomitant MVR 0.675 (0.316–1.442) 0.311
LA dilatation 0.929 (0.441–1.958) 0.846
Early re-operation 1.348 (0.587–3.097) 0.481
AAD=Antiarrhythmic drugs, AF= Atrial fibrillation, CI=Confidence interval, HR=Hazard ratio, LA= Left atrium, MVR=Mitral valve repair or replacement, NYHA=NewYork Heart
Association.
Table 3
Factors associated with late post-operative atrial fibrillation.
Determinant Univariate analysis HR (95% CI) p-value Multivariate analysis HR (95% CI) p-value
Age at repair 1.016 (0.996–1.037) 0.123 1.006 (0.984–1.029) 0.578
Female sex 0.888 (0.495–1.592) 0.690
Diabetes 0.915 (0.218–3.831) 0.903
Hypertension 0.734 (0.326–1.648) 0.453
Hypercholesterolemia 0.990 (0.382–2.565) 0.983
Concomitant MVR 0.948 (0.509–1.767) 0.868
Early POAF (with history of AF) 5.539 (2.665–11.554) <0.001 4.299 (2.203–8.387) <0.001
Early POAF de novo 2.182 (1.099–4.331) 0.026 3.138 (1.450–6.789) 0.004
AF= Atrial fibrillation, CI=Confidence interval, HR = Hazard ratio, MVR= Mitral valve repair or replacement, POAF = Post-operative atrial fibrillation.
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Females (n = 144, 42%) had a significantly higher age at time of
surgery compared to males (p = 0.01, ♀ 57.8y [41.9–66.3], ♂ 51.9y
[37.9–61.5]), yet the prevalence of AF at baseline (p = 0.62) in male
and female patients was comparable. Relatively more females (n = 62
(79.5%)) were in NYHA III-IV compared to males (n = 89 (71.7%)), but
this difference did not reach statistical significance (p=0.22). The pres-
ence of comorbidities (p>0.3) inmale and female patients is similar, ex-
cept for hypercholesterolemiawhich occurredmore frequently in female
patients (p = 0.02). There were no sex differences in the usage of anti-
arrhythmic drugs (all p>0.06). Early and late post-operative AF (respec-
tively p=0.60 and p=0.84) and post-operative pacemaker (p=0.92)




This is the first report on the clinical course of post-operative AF, AFL
and other SVTs in a substantial group of patients with HOCM undergo-
ing surgical myectomy. Our data demonstrate that this population is
at high risk of developing both early- and late post-operative AF. Pa-
tients who had de novo AF early after myectomy had a more than 3
times higher risk for developing AF during a median follow-up of
3 years. The prevalence and incidence of AF were comparable between
male and female patients. Factors associatedwith late post-operative AF
and AFL included older age at surgery, history of AF and occurrence of
early post-operative AF. In our cohort, the high incidence of AF wastrial fibrillation, LSPAF = Longstanding persistent atrial fibrillation, Pers = Persistent.
R.K. Kharbanda, L. Lodder, A.A.Y. Ragab et al. International Journal of Cardiology xxx (xxxx) xxxnot associated with increased mortality rates. However, older age at
time of surgery was independently associated with mortality.
4.2. Pathophysiology of atrial fibrillation in HCM patients
Development of AF in HCM patients is likely a multifactorial process
including genetic factors, atrial- and ventricular structural remodeling
and electrophysiological abnormalities, such as atrial conduction disor-
ders. Genetic mutations encoding sarcomere associated proteins are
present in approximately 60% of HCM patients. Mutations in MYH7
gene (encoding β-myosin heavy chain), MYBPC3 gene (encoding
myosin-binding protein C) and TNNT2 (encoding cardiac troponin
T) are themost common genetic mutations encountered in this popula-
tion. Several studies have demonstrated a higher incidence of AF in pa-
tients with a MYH7 mutation compared to patients with a MYBPC3
mutation [18,19]. More specifically, patients with a β-myosin heavy
chain missense mutation Arg663His have a higher risk of AF and are
characterized by predominantly subaortic interventricular septal hy-
pertrophy [20]. The authors postulated an important role of LVOT hy-
pertrophy as a potential trigger for AF in this population with normal
survival.
A few other studies investigated the relation betweenmultiple poly-
morphisms in the renin-angiotensin-aldosterone system (RAAS) and
the presence of AF [21,22]. HOCMpatients carrying the ‘1166/ polymor-
phism of AGTR1’ and ‘–344T>C polymorphism of CYP11B2’were more
frequently diagnosed with AF. These patients also had higher aldoste-
rone serum levels and a thicker interventricular septum. Increased
serum aldosterone serum levels may promote cardiac remodeling in-
cluding atrial fibrosis, as a potential trigger of AF.
4.3. The incidence of pre-, early- and late post-operative atrial fibrillation
AF is a well-known complication after cardiac surgery and is associ-
ated with prolonged hospital stay, hemodynamic instability, increased
risk of thromboembolic events, increased mortality and subsequently
increased health care costs. It is also known that early post-operative
AF occursmore frequently in patients undergoing valvular surgery com-
pared to patients undergoing coronary artery bypass grafting [23].
HOCM patients undergoing myectomy, often accompanied by mitral
valve repair, are therefore at high risk of developing post-operative AF.
Nevertheless, studies reporting on the incidence and risk factors for
early and late post-operative AF after myectomy are scarce. As a result,
risk prediction-, management- and progression of AF after myectomy
remains unexplored.
The reported prevalence of AF in HOCM patients undergoing
surgical myectomy ranges between 3.4 and 37.5% [4,12,13,15,
24–29]. The majority of these studies, reported a prevalence
around 20–25%, which is in line with the present study (19.7%)
[4,12,15,24,28,29]. In only one study, type of AF was classified
prior to the surgical procedure. Of the 180 patients, (37.5% of
the study population) known with AF, 166 were diagnosed
with paroxysmal AF and the remaining 14 with (longstanding)
persistent AF [25].
In the present study, new-onset- and early post-operative AF were
reported in respectively 22.5% and 33.7% of the patients. These findings
are also comparable with previous studies reporting incidences ranging
between 21 and 30%. [4,12,15,25,26]; only 3 of these studies specified
the incidence of new-onset early post-operative AF (range 2.9%–17.2%)
[12,13,25].
Several factors may explain the lower incidences of new-onset post-
operative AF found in literature compared to the present study. Firstly,
mean age at time of surgery was substantially lower (6–7 years) in
prior studies [12,13]. Secondly, concomitant valve or coronary artery
bypass surgery was more frequently performed in our study (80%)
compared to prior studies (range 10–44%).5
Until now, there were no reports on incidences and progression of
late post-operative AF following transaortic myectomy for HOCM.
With an incidence around 20%, our study demonstrates that post-
operative AF is a common sequela in this population. Moreover, AF
progressed in a considerable number of patients in a relatively short pe-
riod. Future studies investigating the incidence aswell as progression of
AF are therefore essential in order to guide therapy.
4.4. New-onset early post-operative AF after surgical myectomy, transient
or lasting?
New-onset post-operative AF is often regarded as benign, transient
and self-limiting. Whether to discharge HOCM patients with anti-
arrhythmic drugs and oral anticoagulation remains a matter of debate.
Advanced periodic rhythm monitoring (e.g. Holter monitoring) during
follow-up is often at discretion of the treating physician. Our data, how-
ever, implies that new-onset POAF after myectomy is not transient and
is rather independently associated with a higher risk of late post-
operative AF development.
4.5. Concomitant AF surgery, enough evidence to perform?
Studies investigating the efficacy of concomitant AF surgery during
myectomy are limited [30–33]. Therefore, according to the guidelines,
concomitant AF ablation during septal myectomy is considered as a
class 2A indication (evidence level C). The two largest studies reported
an AF free survival rate of 78% [32] at 2 years and 64% [33] at 5 years
after a Maze IV procedure. Left atrial dilatation (≥45 mm in diameter),
increasing age and a higher LVOT gradient at time of surgery were iden-
tified as predictors for AF recurrence. Evidence supporting concomitant
AF ablation duringmyectomy is scarce and recommendations are there-
fore mainly based on outcomes of a few experienced centers.
4.6. Limitations
Continuous rhythm monitoring during follow-up was performed at
the discretion of the treating physician. As a result, silent episodes of
SVTs may not have been detected. As data was acquired retrospectively
without a predetermined follow-up protocol, frequency and follow-up
may differ between patients. In addition, due to incomplete echocardio-
graphic data we were unable to correlate the degree of mitral valve re-
gurgitationwith the occurrence of post-operative arrhythmias. Erasmus
Medical Center is a specialized HOCM center, however HOCM patients
are sometimes followed-up in the referral hospitals. Systematic long-
term follow-up data part of the population was therefore not, or par-
tially, available.
5. Conclusion
Early and late post-operative AF, AFL and SVTs are common sequelae
in patients with HOCMundergoing transaortic myectomy. Factors asso-
ciatedwith development of these tachyarrhythmias include older age at
surgery, history of AF and occurrence of early post-operative AF. De
novo early post-operative AF is associated with a more than 3 times
higher risk of developing late post-operative AF. Moreover, AF
progressed in a considerable number of patients in a relatively short pe-
riod. Early post-operative arrhythmias in HOCM patients are not tran-
sient and periodic rhythm monitoring is therefore essential to initiate
therapy as soon as possible.
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